Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426)

Betsy Plimack discusses the updated data with a minimum of 23 months' follow up. Dr. Brian Rini and Professor Tom Powles asks what it adds. 

2356 232

Suggested Podcasts

IVM Podcasts

The Power Practice

LFC Daytrippers

Founder and CEO of Light the Way, John Wilson

Tinder / Gimlet Creative

Escape Artists Foundation

Michelle Patnode and Joe Carcia

Socially Freezing